Libre, Lance T.

HRN: 20-91-67  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/08/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
12/08/2022
12/14/2022
PO
2 Ml
Q 12
URTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: